Gene · 3860
Papers2,936
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,936
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antimalarial drug discovery: progress and approaches. | Nat Rev Drug Discov | 2023 | 37652975 | PubTator, text mining | PubMed |
| BCL7B, a SWI/SNF complex subunit, orchestrates cancer immunity and stemness. | BMC Cancer | 2023 | 37648998 | PubTator, text mining | PubMed |
| Sinapine thiocyanate exhibited anti-colorectal cancer effects by inhibiting KRT6A/S100A2 axis. | Cancer Biol Ther | 2023 | 37647260 | PubTator, text mining | PubMed |
| Optimization of Cu/Sn Alloy Sputtering Process Based on Orthogonal Experimental Design Method. | Micromachines (Basel) | 2023 | 37630075 | PubTator, text mining | PubMed |
| The Post-Translational Modifications of Human Salivary Peptides and Proteins Evidenced by Top-Down Platforms. | Int J Mol Sci | 2023 | 37628956 | PubTator, text mining | PubMed |
| Homeobox Gene Expression Dysregulation as Potential Diagnostic and Prognostic Biomarkers in Bladder Cancer. | Diagnostics (Basel) | 2023 | 37627900 | PubTator, text mining | PubMed |
| Molecular surveillance of Plasmodium falciparum drug-resistance markers in Vietnam using multiplex amplicon sequencing (2000-2016). | Sci Rep | 2023 | 37626131 | PubTator, text mining | PubMed |
| New advances in circulating tumor cell‑mediated metastasis of breast cancer (Review). | Mol Clin Oncol | 2023 | 37614367 | PubTator, text mining | PubMed |
| Molecular detection of drug-resistant Plasmodium falciparum mutants in Assam. | Indian J Med Res | 2023 | 37602587 | PubTator, text mining | PubMed |
| Reanalysis of Single-Cell RNA-Sequencing Data in Patients with COVID-19: Insights and Limitations. | Am J Respir Cell Mol Biol | 2023 | 37590905 | PubTator, text mining | PubMed |
| Nationwide spatiotemporal drug resistance genetic profiling from over three decades in Indian Plasmodium falciparum and Plasmodium vivax isolates. | Malar J | 2023 | 37582796 | PubTator, text mining | PubMed |
| Establishment of a prognostic model toward lung squamous cell carcinoma based on m7G-related genes in the cancer genome atlas. | Physiol Genomics | 2023 | 37575065 | PubTator, text mining | PubMed |
| MAGI1 Prevents Senescence and Promotes the DNA Damage Response in ER+ Breast Cancer. | Cells | 2023 | 37566008 | PubTator, text mining | PubMed |
| Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin-piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia. | Malar J | 2023 | 37553646 | PubTator, text mining | PubMed |
| Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer. | Nat Commun | 2023 | 37553345 | PubTator, text mining | PubMed |
| Reaction hijacking inhibition of Plasmodium falciparum asparagine tRNA synthetase. | Res Sq | 2023 | 37546892 | PubTator, text mining | PubMed |
| Adenoid Ameloblastoma Shares Clinicopathologic, Immunohistochemical, and Molecular Features With Dentinogenic Ghost Cell Tumor: A Comparative Analysis. | Am J Surg Pathol | 2023 | 37545355 | PubTator, text mining | PubMed |
| Rare FGFR fusion genes in cervical cancer and transcriptome-based subgrouping of patients with a poor prognosis. | Cancer Med | 2023 | 37537783 | PubTator, text mining | PubMed |
| Meta-Analysis of COVID-19 BAL Single-Cell RNA Sequencing Reveals Alveolar Epithelial Transitions and Unique Alveolar Epithelial Cell Fates. | Am J Respir Cell Mol Biol | 2023 | 37523502 | PubTator, text mining | PubMed |
| Comparison between Cultivated Oral Mucosa and Ocular Surface Epithelia for COMET Patients Follow-Up. | Int J Mol Sci | 2023 | 37511281 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3860/papers?page=11